Sort
11,323 grants matching “glioblastoma”
Apical-basal polarity signaling in glioblastoma
$332,942Sourav Ghosh · University Of Arizona · R01 · FY2010 · CA
Cyclophilin B as a therapeutic target in glioblastoma
$332,895Richard J Bram · Mayo Clinic Rochester · R01 · FY2013 · NS
Correlative Studies and Immune Monitoring Core
$332,892Kent J. Weinhold · Duke University · P01 · FY2019 · CA
Project 2: Clinical evaluation of a novel oHSV in recurrent human GBM
$332,873E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2022 · CA
Nutritional Control of Cancer Cell Function by Amino Acids
$332,830Michael S. Kilberg · University Of Florida · R01 · FY2019 · CA
INDIVIDUALIZING IMRT TREATMENT IN BRAIN AND HEAD/NECK CA
$332,796Avraham Eisbruch · University Of Michigan At Ann Arbor · P01 · FY2008 · CA
Autophagy in Brain Tumor
$332,771Jin-Ming Yang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2009 · CA
Rho- and GPCR-mediated signaling through novel cellular effectors
$332,678Joan Heller Brown · University Of California, San Diego · R01 · FY2010 · GM
The Ureb-1 ubiquitin ligase in neural stem cells and cancer
$332,623Anna Lasorella · Columbia University Health Sciences · R01 · FY2008 · CA
The Ureb-1 ubiquitin ligase in neural stem cells and cancer
$332,623Anna Lasorella · Columbia University Health Sciences · R01 · FY2009 · CA
New Vectors and Delivery Systems for Glioblastoma Therapy
$332,601Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2010 · CA
Molecular mechanisms that regulate ADAR target recognition and RNA editing in vivo
$332,451Heather Ann Hundley · Trustees Of Indiana University · R01 · FY2023 · GM
Molecular mechanisms that regulate ADAR target recognition and RNA editing in vivo
$332,451Heather Ann Hundley · Trustees Of Indiana University · R01 · FY2022 · GM
Novel role of compensatory proliferation in human brain tumor
$332,436Ichiro Nakano · University Of Alabama At Birmingham · R01 · FY2016 · CA
Cytokine Signaling in Glioblastoma Cells
$332,425Saikh J Haque · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · CA
Reversal of CMV-specific immune deficits in patients with glioblastoma
$332,401Duane A. Mitchell · Duke University · R01 · FY2012 · NS
Reversal of CMV-specific immune deficits in patients with glioblastoma
$332,401Duane A. Mitchell · Duke University · R01 · FY2011 · NS
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
$332,363Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2016 · CA
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
$332,363Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2017 · CA
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
$332,363Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2015 · CA
Elucidating the role of new RasGAP tumor suppressors in cancer
$332,291Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2018 · CA
Elucidating the role of new RasGAP tumor suppressors in cancer
$332,291Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2016 · CA
Elucidating the role of new RasGAP tumor suppressors in cancer
$332,291Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2017 · CA
Inhibition of glioma tumor growth by antisense MMP-9
$332,281Jasti S Rao · University Of Illinois At Chicago · R01 · FY2011 · NS
Elucidating the role of new RasGAP tumor suppressors in cancer
$332,224Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2015 · CA